Martin Wermke

16PUBLICATIONS

107CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersGene and molecular therapyLiquid biopsies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Jun 19, 2026

Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

|May 31, 2026

MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

|Jan 22, 2026

Reply to: Delta-Like Ligand 3 Expression Across Lung Neuroendocrine Subtypes: Interpreting Response in Small Cell Lung Cancer and Beyond.

Martin Wermke, Valentina Gambardella, Yasutoshi Kuboki

|Sep 27, 2025

First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms.

Simone Thomas, Martin Wermke, Vladan Vučinić

|Sep 04, 2025

Histologic Transformation in Cancer: The Path for Clinical Translation.

Ioannis Vathiotis, Avisek Banerjee, Utsav Sen

|Jul 24, 2025

Phase I Dose-Escalation Results for the Delta-Like Ligand 3/CD3 IgG-Like T-Cell Engager Obrixtamig (BI 764532) in Patients With Delta-Like Ligand 3+ Small Cell Lung Cancer or Neuroendocrine Carcinomas.

Martin Wermke, Valentina Gambardella, Yasutoshi Kuboki

Pageof 3

Frequent Collaborators

4 joint publications

Cedrik Michael Britten

Norbert Hilf

Yael C Cohen

Kristin Henson

Fredrik Schjesvold

Enrique M Ocio

Carsten Reinhardt

Jonathan L Kaufman

Andrew Spencer

Jürgen Wolf

Frequent Collaborators

4 joint publications

Cedrik Michael Britten

4 joint publications

Norbert Hilf

2 joint publications

Yael C Cohen

2 joint publications

Kristin Henson